TY - JOUR
T1 - Longitudinal evaluation of visual P300 amplitude in clinical high-risk subjects
T2 - An event-related potential study
AU - Oribe, Naoya
AU - Hirano, Yoji
AU - del Re, Elisabetta
AU - Mesholam-Gately, Raquelle I.
AU - Woodberry, Kristen A.
AU - Ueno, Takefumi
AU - Kanba, Shigenobu
AU - Onitsuka, Toshiaki
AU - Shenton, Martha E.
AU - Spencer, Kevin M.
AU - Niznikiewicz, Margaret A.
N1 - Publisher Copyright:
© 2020 The Authors Psychiatry and Clinical Neurosciences © 2020 Japanese Society of Psychiatry and Neurology
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Aim: We previously reported abnormal P300 and N200 in a visual oddball task, and progressive P300 amplitude reduction at 1-year follow-up in patients with first-episode schizophrenia. P300 reduction as well as intact P1/N1 were also observed in clinical high-risk subjects (CHR), but whether or not these components change over time is unknown. This study evaluates, longitudinally, the visual P300, as well as P1, N1, and N200, in CHR. Methods: Visual event-related potentials (ERP) were recorded twice, once at baseline and once at 1-year follow-up in CHR (n = 19) and healthy comparison subjects (HC; n = 28). Participants silently counted infrequent target stimuli (‘x’) among standard stimuli (‘y’) presented on the screen while the 64-channel electroencephalogram was recorded. Results: No CHR converted to psychosis from baseline to 1-year follow-up in this study. Visual P300 amplitude was reduced and the latency was delayed significantly in CHR at both time points compared with HC. Furthermore, CHR subjects who had more positive symptoms showed more amplitude reduction at both time points. P1, N1, and N200 did not differ between groups. Conclusion: Visual P300 amplitude was found to be reduced in CHR individuals compared with HC. We note that this finding is in subjects who did not convert to psychosis at 1-year follow-up. The association between visual P300 amplitude and symptoms suggests that for CHR who often experience clinical symptoms and seek medical care, visual P300 may be an important index that reflects the pathophysiological impairment underlying such clinical states.
AB - Aim: We previously reported abnormal P300 and N200 in a visual oddball task, and progressive P300 amplitude reduction at 1-year follow-up in patients with first-episode schizophrenia. P300 reduction as well as intact P1/N1 were also observed in clinical high-risk subjects (CHR), but whether or not these components change over time is unknown. This study evaluates, longitudinally, the visual P300, as well as P1, N1, and N200, in CHR. Methods: Visual event-related potentials (ERP) were recorded twice, once at baseline and once at 1-year follow-up in CHR (n = 19) and healthy comparison subjects (HC; n = 28). Participants silently counted infrequent target stimuli (‘x’) among standard stimuli (‘y’) presented on the screen while the 64-channel electroencephalogram was recorded. Results: No CHR converted to psychosis from baseline to 1-year follow-up in this study. Visual P300 amplitude was reduced and the latency was delayed significantly in CHR at both time points compared with HC. Furthermore, CHR subjects who had more positive symptoms showed more amplitude reduction at both time points. P1, N1, and N200 did not differ between groups. Conclusion: Visual P300 amplitude was found to be reduced in CHR individuals compared with HC. We note that this finding is in subjects who did not convert to psychosis at 1-year follow-up. The association between visual P300 amplitude and symptoms suggests that for CHR who often experience clinical symptoms and seek medical care, visual P300 may be an important index that reflects the pathophysiological impairment underlying such clinical states.
UR - http://www.scopus.com/inward/record.url?scp=85088264080&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088264080&partnerID=8YFLogxK
U2 - 10.1111/pcn.13083
DO - 10.1111/pcn.13083
M3 - Article
C2 - 32519778
AN - SCOPUS:85088264080
SN - 1323-1316
VL - 74
SP - 527
EP - 534
JO - Psychiatry and clinical neurosciences
JF - Psychiatry and clinical neurosciences
IS - 10
ER -